ストックスクリーナーアプリを入手
16.81
4.06%
-0.6874
前日終値:
$17.50
開ける：
$17.26
24時間の取引高:
203.10K
Relative Volume:
0.54
時価総額：
$5.96B
収益：
$5.10B
当期純損益:
$-352.00M
株価収益率:
-16.50
EPS:
-1.0189
ネットキャッシュフロー:
$-66.14M
1週間 パフォーマンス:
-4.60%
1か月 パフォーマンス:
+0.36%
6か月 パフォーマンス:
+10.53%
1年 パフォーマンス:
+10.17%
1日の値動き範囲:
$16.66
$17.28
1週間の範囲:
$16.66
$17.68
52週間の値動き範囲:
$10.45
$18.91
Bausch Lomb Corp Stock (BLCO) Company Profile
Compare BLCO vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
16.82 | 6.20B | 5.10B | -352.00M | -66.14M | -1.0189 |
|
ISRG
Intuitive Surgical Inc
|
475.00 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.68 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.66 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
233.12 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.39 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | 開始されました | Goldman | Neutral |
| 2025-05-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-03-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-07-10 | 開始されました | Raymond James | Outperform |
| 2024-05-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-12 | 開始されました | Stifel | Hold |
| 2023-10-03 | 再開されました | Evercore ISI | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-09 | 開始されました | Needham | Hold |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-09-12 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-06-24 | 開始されました | Evercore ISI | Outperform |
| 2022-06-06 | 開始されました | Citigroup | Buy |
| 2022-05-31 | 開始されました | Deutsche Bank | Hold |
| 2022-05-31 | 開始されました | Goldman | Neutral |
| 2022-05-31 | 開始されました | Guggenheim | Buy |
| 2022-05-31 | 開始されました | JP Morgan | Neutral |
| 2022-05-31 | 開始されました | Jefferies | Buy |
| 2022-05-31 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 開始されました | Wells Fargo | Overweight |
| 2022-05-11 | 開始されました | Cowen | Outperform |
すべてを表示
Bausch Lomb Corp (BLCO) 最新ニュース
Citi Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Bausch And Lomb (NYSE:BLCO) Glaucoma Moves Catch Market Eyes Nyse Composite Today - Kalkine Media
Bausch + Lomb Corporation - Baystreet.ca
Inside Bausch + Lomb’s glaucoma webinar on new treatments - Stock Titan
Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Latest Revenue And Net Loss Update - Yahoo Finance
Short Covering: Will Bausch Lomb Corporation outperform its industry peersJuly 2025 Levels & Fast Moving Market Watchlists - baoquankhu1.vn
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - Finviz
Insider Buying: Ross Thomas W. Sr. Acquires Shares in Bausch & L - GuruFocus
Director adds BLCO stake with 4,500-share buy and 4,500 RSUs grant - Stock Titan
Insider Buying: Eduardo Alfonso Acquires Shares of Bausch & Lomb Corp (BLCO) - GuruFocus
[Form 4] Bausch & Lomb Corp Insider Trading Activity - Stock Titan
Bausch & Lomb (NYSE: BLCO) director buys shares, gets RSUs - Stock Titan
BLCO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bausch & Lomb (NYSE: BLCO) SVP disposes shares for taxes - Stock Titan
Bausch & Lomb (BLCO) officer has shares withheld for RSU tax - Stock Titan
Tax-withholding share moves by Bausch & Lomb (NYSE: BLCO) executive - Stock Titan
Bausch & Lomb (BLCO) EVP uses share withholding to cover tax on RSU vesting - Stock Titan
Bausch & Lomb (BLCO) EVP uses shares for tax withholding on RSU vesting - Stock Titan
CFO tax share withholding at Bausch & Lomb (BLCO) after RSU vesting - Stock Titan
Bausch & Lomb (BLCO) CEO uses common shares to cover RSU tax - Stock Titan
Bausch & Lomb (BLCO) SVP awarded 18,253 restricted share units in Form 4 - Stock Titan
Executive at Bausch & Lomb (NYSE: BLCO) granted 32,710 restricted share units - Stock Titan
Bausch & Lomb (NYSE: BLCO) EVP awarded 35,046 restricted share units - Stock Titan
327,102-share RSU award to Bausch & Lomb (BLCO) CEO Brent Saunders - Stock Titan
Bausch + Lomb Corp. Hits New 52-Week High at $18.91 - Markets Mojo
Bausch + Lomb Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth - Insider Monkey
Bausch + Lomb stock hits 52-week high at $18.86 - Investing.com Australia
Bausch + Lomb stock hits 52-week high at $18.86 By Investing.com - Investing.com Canada
Bausch & Lomb (BLCO) CEO uses 65,444 shares to cover tax withholding - Stock Titan
Is Expert Backing Of LUMIFY’s Safety Profile Quietly Shaping Bausch + Lomb’s Consumer Strategy (BLCO)? - simplywall.st
Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036 - GlobeNewswire Inc.
5 Revealing Analyst Questions From Bausch + Lomb's Q4 Earnings Call - Finviz
Director Steven Collis adds BLCO stake with 15,000-share buy and RSU grant - Stock Titan
Director boosts Bausch & Lomb (BLCO) stake with share buy and matching RSUs - Stock Titan
Is It Time To Reassess Bausch + Lomb (BLCO) After Its Recent Share Price Strength? - Yahoo Finance
H.C. Wainwright raises Bausch & Lomb stock price target to $20 - Investing.com South Africa
H.C. Wainwright raises Bausch & Lomb stock price target to $20 By Investing.com - Investing.com Canada
HC Wainwright Comments on Bausch + Lomb Q1 Earnings - MarketBeat
Digital lifestyles are turning eyes red – and one drop stands out - Stock Titan
Adding B Vitamins To AREDS Has Bausch + Lomb Seeing Consumer Health Sales Boost Ahead - Citeline News & Insights
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey
Director Karen Ling adds Bausch & Lomb (BLCO) shares and gets 4,000 RSUs - Stock Titan
Director receives 5,255 RSUs at Bausch & Lomb (NYSE: BLCO) - Stock Titan
Bausch & Lomb (BLCO) awards 5,255 RSUs to director - Stock Titan
Director at Bausch & Lomb (BLCO) receives 1,451 restricted share units - Stock Titan
Director John Paulson granted 1,239 Bausch & Lomb (BLCO) restricted share units - Stock Titan
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $20 - 富途牛牛
Bausch & Lomb (NYSE: BLCO) EVP earns 29,406 performance-based shares - Stock Titan
Stifel raises Bausch & Lomb stock price target on strong Miebo sales - Investing.com South Africa
Deutsche Bank Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $18 - 富途牛牛
Bausch Lomb Corp (BLCO) 財務データ
収益
当期純利益
現金流量
EPS
2.91%
大文字化:
|
ボリューム (24 時間):